Anti-Cancer Agents in Medicinal Chemistry
Title:Editorial: Teratology and Reproductive Toxicology of Anticancer Agents
Volume: 17 Issue: 9
Author(s): Gian Mario Tiboni
Affiliation:
Export Options
About this article
Cite this article as:
Tiboni Mario Gian , Editorial: Teratology and Reproductive Toxicology of Anticancer Agents, Anti-Cancer Agents in Medicinal Chemistry 2017; 17 (9) . https://dx.doi.org/10.2174/187152061709170912113703
DOI https://dx.doi.org/10.2174/187152061709170912113703 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
27
2
2
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells
Current Medicinal Chemistry Biosafety of Herpesvirus Vectors
Current Gene Therapy Predicting Pediatric Drug Disposition-Present and Future Directions of Pediatric Physiologically-Based Pharmacokinetics
Drug Metabolism Letters Long Term Cardiovascular Risk in Women
Vascular Disease Prevention (Discontinued) Redox State, Oxidative Stress, and Molecular Mechanisms of Protective and Toxic Effects of Bilirubin on Cells
Current Pharmaceutical Design C-Reactive Protein: Interaction with the Vascular Endothelium and Possible Role in Human Atherosclerosis
Current Pharmaceutical Design Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma
Current Cancer Therapy Reviews Recent Advances in Iron-Catalyzed C-H Bond Activation Reactions
Current Inorganic Chemistry (Discontinued) Modulation of the Cell Cycle and Induction of Apoptosis in Human Cancer Cells by Synthetic Bile Acids
Current Cancer Drug Targets Development of a PBPK Model for Monoclonal Antibodies and Simulation of Human and Mice PBPK of a Radiolabelled Monoclonal Antibody
Current Pharmaceutical Design Ghetto Poverty and Pollution in Egypt: A Deadly Threat for Western Countries Caused by New and Infectious Mutants. A Cultural, Social and Microbiological Synopsis
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacotherapy of Sickle Cell Disease in Children
Current Pharmaceutical Design Contemporary Pediatric Palliative Care: Myths and Barriers to Integration into Clinical Care
Current Pediatric Reviews Aligning Animal Models of Clinical Germinal Matrix Hemorrhage, From Basic Correlation to Therapeutic Approach
Current Drug Targets Human Pluripotent Stem Cells for Modelling Human Liver Diseases and Cell Therapy
Current Gene Therapy Editorial
Current Medical Imaging The Formulation of Lipid-Based Nanotechnologies for the Delivery of Fixed Dose Anticancer Drug Combinations
Current Drug Delivery The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials
Current Cancer Therapy Reviews Investigation of the Metabolism of Rufinamide and Its Interaction with Valproate
Drug Metabolism Letters Pharmacogenomic Approaches to Osteoporosis: 2005 Update
Current Pharmacogenomics